Satu Lakio, PhD, is the Pharmaceutical Development Manager at Nanoform. She earned her PhD at the University of Helsinki, Finland, focusing on enhancing the understanding of pharmaceutical powder processing. Dr Lakio completed her postdoctoral research at Monash University in Melbourne, Australia, studying inhalation powder.
She has previously worked in several positions within academia and as an Associate Principal Scientist at AstraZeneca and Senior Development Manager at Orion Pharma. Dr Lakio holds an adjunct professorship at the University of Helsinki and University of Eastern Finland (Pharmaceutical technology). Currently, her research focuses on the pharmaceutical development of nanoformed™ particles.